RECRUITING

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People with Breast Cancer

Talk to us

Conditions

LymphedemaLymphedema ArmLymphedema of Upper ArmBreast CancerBreast CarcinomaFemale Breast Cancerimmediate lymphatic reconstructionaxillary lymph node dissectionMemorial Sloan Kettering Cancer Center23-303

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.

Official Title

A Prospective Cohort Study of Patients Undergoing ALND for Treatment of Breast Cancer: the Efficacy of a Comprehensive Prevention Program in Decreasing the Incidence of Lymphedema and Improving Quality of Life

Quick Facts

Study Start:2023-11-16
Study Completion:2030-03-16
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06144164

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 75 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Female sex
  2. * Diagnosis of breast cancer
  3. * Ages 18 to 75 years
  4. * Consented for unilateral ALND or for unilateral SLNB with possible ALND
  1. * Male sex
  2. * Does not speak English
  3. * Does not fit into study garment
  4. * Axillary recurrence
  5. * History of ALND
  6. * Requirement of bilateral ALND for the treatment of breast cancer
  7. * Treatment with SLNB only
  8. * Known anaphylactic allergy to ICG dye used in ILR
  9. * Impaired decision-making capacity

Contacts and Locations

Study Contact

Michelle Coriddi, MD
CONTACT
646-608-8042
coriddim@mskcc.org
Babak Mahrara, MD
CONTACT
646-608-8085
mehrarab@MSKCC.ORG

Principal Investigator

Michelle Coriddi, MD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, 07920
United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, New Jersey, 07748
United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, 07645
United States
Memorial Sloan Kettering Commack (Limited Protocol Activities)
Commack, New York, 11725
United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, New York, 10604
United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065
United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, New York, 11553
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Michelle Coriddi, MD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-16
Study Completion Date2030-03-16

Study Record Updates

Study Start Date2023-11-16
Study Completion Date2030-03-16

Terms related to this study

Keywords Provided by Researchers

  • immediate lymphatic reconstruction
  • axillary lymph node dissection
  • Lymphedema
  • Lymphedema Arm
  • Lymphedema of Upper Arm
  • Breast cancer
  • breast carcinoma
  • female breast cancer
  • Memorial Sloan Kettering Cancer Center
  • 23-303

Additional Relevant MeSH Terms

  • Lymphedema
  • Lymphedema Arm
  • Lymphedema of Upper Arm
  • Breast Cancer
  • Breast Carcinoma
  • Female Breast Cancer